Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Juan Antonio Requena-Ibanez"'
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)
Externí odkaz:
https://doaj.org/article/dd6ceb9073704e9cb5d917d7f0fee5e7
Autor:
Anderly Rodriguez-Cordero, Valentin Fuster, Ariana P. Vargas-Delgado, Chiara Giannarelli, Javier Sanz, Juan J. Badimon, Frank Macaluso, Farah Atallah-Lajam, Donna M. Mancini, Juan Antonio Requena-Ibanez, Anuradha Lala, Samantha Sartori, Carlos G. Santos-Gallego
Publikováno v:
JACC: Heart Failure. 9:578-589
Objectives The goal of this study was to evaluate the effect of empagliflozin, in addition to optimal medical treatment, on epicardial adipose tissue (EAT), interstitial myocardial fibrosis, and aortic stiffness in nondiabetic patients with heart fai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b032c45173c4d68c3303aa43c2c905c2
https://doi.org/10.1016/j.jchf.2021.04.014
https://doi.org/10.1016/j.jchf.2021.04.014
Autor:
Juan Antonio Requena-Ibanez, Valentin Fuster, Carlos G. Santos-Gallego, Samantha Sartori, Anderly José Rodriguez Cordero, Brian Fardman, Javier Sanz, Juan J. Badimon
Publikováno v:
Magnetic Resonance Imaging. 86:149-151
Epicardial Adipose Tissue (EAT) is drawing increasing attention. As a quantifiable, modifiable, and potentially new cardiovascular therapeutic target, its accurate measurement is particularly relevant. In Cardiac Magnetic Resonance (CMR) different me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795ff6fe74d000e125d41b48293bf247
https://doi.org/10.1016/j.mri.2021.11.004
https://doi.org/10.1016/j.mri.2021.11.004
Publikováno v:
Cardiovascular Drugs and Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5993fe9859115e5624904241c867428
https://doi.org/10.1007/s10557-022-07371-7
https://doi.org/10.1007/s10557-022-07371-7
Autor:
Carlos G. Santos-Gallego, Juan J. Badimon, Juan Antonio Requena Ibanez, Ariana P. Vargas Delgado
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 33:33-40
Resumen Los inhibidores del cotransportador de sodio-glucosa tipo 2 (iSGLT2) fueron incialmente desarrollados para el tratamiento de la diabetes por su actividad hipoglucemiante. Sin embargo, a la luz de los estudios clinicos mas recientes, estan rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29908927e9540a9f9d3ff61675205dfe
https://doi.org/10.1016/j.arteri.2020.08.001
https://doi.org/10.1016/j.arteri.2020.08.001
Autor:
Anuradha Lala, Sean Pinney, Empa-Tropism (Atru ) Investigators, M. Urooj Zafar, Alvaro Garcia-Ropero, Javier Sanz, Icilma V. Fergus, Juan J. Badimon, Carlos G. Santos-Gallego, Vivian M. Abascal, Valentin Fuster, Juan Antonio Requena-Ibanez, Mercè Roqué, Donna M. Mancini, Ariana P. Vargas-Delgado, Ronald Tamler, Pedro R. Moreno, Fernando Sabatel-Perez, Farah Atallah-Lajam, Frank Macaluso, Cathleen Varley, Samantha Sartori, Johanna Contreras, Anderly Rodriguez-Cordero
Publikováno v:
Journal of the American College of Cardiology. 77:243-255
Large clinical trials established the benefits of sodium-glucose cotransporter 2 inhibitors in patients with diabetes and with heart failure with reduced ejection fraction (HFrEF). The early and significant improvement in clinical outcomes is likely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9da2adf6daab5cd4bd3b6863519f5f
https://doi.org/10.1016/j.jacc.2020.11.008
https://doi.org/10.1016/j.jacc.2020.11.008
Autor:
Ariana P. Vargas Delgado, Juan Antonio Requena Ibanez, Juan J. Badimon, Carlos G. Santos-Gallego
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 33:33-40
The sodium-glucose co-transporter 2 inhibitors (SGLT2i) were first conceived to treat type 2 diabetes due to their hypoglycaemic effect. However, due to an increasing number of studies, SGLT2i are changing the way we treat, and understand, diabetes,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be4d288973976f58b0c2f8db9be525d1
https://doi.org/10.1016/j.artere.2020.12.004
https://doi.org/10.1016/j.artere.2020.12.004
Autor:
Sean Pinney, Johanna Contreras, Valentin Fuster, Carlos G. Santos-Gallego, Alvaro Garcia-Ropero, Anderly Rodriguez-Cordero, Pedro R. Moreno, Ariana P Vargas, Juan Antonio Requena-Ibanez, Anuradha Lala, Donna M. Mancini, Javier Sanz, Juan J. Badimon
Publikováno v:
Circulation. 142
Background: SGLT2 inhibitors (SGLT2i) improve prognosis in HFrEF patients. We recently demonstrated in a porcine model of non-diabetic HFrEF that empagliflozin (EMPA) ameliorates adverse cardiac remodeling and improves LV systolic function. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e38cca174ba0d2bf176e166e08ec2f5
https://doi.org/10.1161/circ.142.suppl_3.17275
https://doi.org/10.1161/circ.142.suppl_3.17275
Autor:
Pedro R. Moreno, Ariana P Vargas, Carlos G. Santos-Gallego, Javier Sanz, Donna M. Mancini, Juan J. Badimon, Sean Pinney, Valentin Fuster, Alvaro Garcia-Ropero, Anderly Rodriguez-Cordero, Johanna Contreras, Anuradha Lala, Juan Antonio Requena-Ibanez
Publikováno v:
Circulation. 142
Background: SGLT2 inhibitors (SGLT2i) improve prognosis in HFrEF patients. We recently demonstrated in a porcine model of non-diabetic HFrEF that empagliflozin (EMPA) ameliorates adverse cardiac remodeling and improves LV systolic function. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdc9a321806ef0082cd0a0fb530d02d6
https://doi.org/10.1161/circ.142.suppl_3.17157
https://doi.org/10.1161/circ.142.suppl_3.17157
Autor:
Juan Antonio Requena-Ibanez, Kiyotake Ishikawa, Alvaro Garcia-Ropero, Ariana P. Vargas-Delgado, Belén Picatoste, José Tuñón, Carlos G. Santos-Gallego, Javier Sanz, Juan J. Badimon
The sodium-glucose cotransporter type 2 inhibitors reduce mortality and heart failure (HF) hospitalizations. The underlying mechanisms remain unclear but seem to be irrespective of glucose-lowering properties. This study aims to evaluate the impact o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2505bb704da0be7a545142bd387c5334
